Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
8,484,410
-
Share change
-
+2,468,133
-
Total reported value
-
$30,665,000
-
Price per share
-
$3.61
-
Number of holders
-
9
-
Value change
-
+$8,984,489
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2014
As of 31 Dec 2014,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,484,410 shares.
The largest 9 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, DEUTSCHE BANK AG\, Cheyne Capital Management (UK) LLP, BANK OF MONTREAL /CAN/, ROYAL BANK OF CANADA, and Tower Research Capital LLC (TRC).
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.